FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2403409882> ?p ?o ?g. }

• W2403409882 endingPage "37" @default.
• W2403409882 startingPage "32" @default.
• W2403409882 abstract "Purpose of review Optimal asthma management includes both the control of asthma symptoms and reducing the risk of future asthma exacerbations. Traditionally, treatment has been adjusted largely on the basis of symptoms and lung function and for many patients, this approach delivers both excellent symptom control and reduced risk. However, the relationship between these two key components of the disease may vary between different asthmatic phenotypes and disease severities and there is increasing recognition of the need for more individualized treatment approaches. Recent findings A number of factors which predict exacerbation risk have been identified including demographic and behavioural features and specific inflammatory biomarkers. Type-2 cytokine-driven eosinophilic airways inflammation predisposes to frequent exacerbations and predicts response to corticosteroids, and the usefulness of sputum eosinophilia as both a marker of exacerbation risk and biomarker for adjustment of corticosteroid treatment has been established for some time. However, attempts to develop surrogate markers, which would be more straightforward to deliver in the clinic, have been challenging. Summary Some patients with asthma have persistent symptoms in the absence of type-2 cytokine driven-eosinophilic airways inflammation due to noncorticosteroid responsive mechanisms (T2-low disease). Composite biomarker strategies using easily measured surrogate indicators of type-2 inflammation (such as fractional exhaled nitric oxide, blood eosinophil count and serum periostin levels) may predict exacerbation risk better but it is unclear if they can be used to adjust corticosteroid treatment. Biomarkers will be used to target novel biologic treatments but additionally may be used to optimize corticosteroid treatment dose and act as prognostics for exacerbation risk and potentially other important longer term asthma outcomes." @default.
• W2403409882 created "2016-06-24" @default.
• W2403409882 creator A5011606845 @default.
• W2403409882 creator A5072687303 @default.
• W2403409882 date "2016-01-01" @default.
• W2403409882 modified "2023-10-18" @default.
• W2403409882 title "Asthma control and exacerbations" @default.
• W2403409882 cites W1490566496 @default.
• W2403409882 cites W1687346534 @default.
• W2403409882 cites W2006322507 @default.
• W2403409882 cites W2039930386 @default.
• W2403409882 cites W2043649873 @default.
• W2403409882 cites W2063801679 @default.
• W2403409882 cites W2069695034 @default.
• W2403409882 cites W2077644660 @default.
• W2403409882 cites W2080660099 @default.
• W2403409882 cites W2081733717 @default.
• W2403409882 cites W2086769142 @default.
• W2403409882 cites W2090060910 @default.
• W2403409882 cites W2097278538 @default.
• W2403409882 cites W2098276532 @default.
• W2403409882 cites W2099622535 @default.
• W2403409882 cites W2100578775 @default.
• W2403409882 cites W2104718344 @default.
• W2403409882 cites W2106682746 @default.
• W2403409882 cites W2106715003 @default.
• W2403409882 cites W2114114902 @default.
• W2403409882 cites W2127874262 @default.
• W2403409882 cites W2135205747 @default.
• W2403409882 cites W2138355864 @default.
• W2403409882 cites W2150035260 @default.
• W2403409882 cites W2154263136 @default.
• W2403409882 cites W2160134481 @default.
• W2403409882 cites W2164132449 @default.
• W2403409882 cites W2170366579 @default.
• W2403409882 cites W2327256856 @default.
• W2403409882 cites W2601675613 @default.
• W2403409882 cites W2616424562 @default.
• W2403409882 doi "https://doi.org/10.1097/mcp.0000000000000222" @default.
• W2403409882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26574716" @default.
• W2403409882 hasPublicationYear "2016" @default.
• W2403409882 type Work @default.
• W2403409882 sameAs 2403409882 @default.
• W2403409882 citedByCount "12" @default.
• W2403409882 countsByYear W24034098822016 @default.
• W2403409882 countsByYear W24034098822017 @default.
• W2403409882 countsByYear W24034098822018 @default.
• W2403409882 countsByYear W24034098822019 @default.
• W2403409882 countsByYear W24034098822020 @default.
• W2403409882 countsByYear W24034098822023 @default.
• W2403409882 crossrefType "journal-article" @default.
• W2403409882 hasAuthorship W2403409882A5011606845 @default.
• W2403409882 hasAuthorship W2403409882A5072687303 @default.
• W2403409882 hasConcept C126322002 @default.
• W2403409882 hasConcept C142724271 @default.
• W2403409882 hasConcept C177713679 @default.
• W2403409882 hasConcept C185592680 @default.
• W2403409882 hasConcept C189165786 @default.
• W2403409882 hasConcept C203014093 @default.
• W2403409882 hasConcept C2776042228 @default.
• W2403409882 hasConcept C2776301714 @default.
• W2403409882 hasConcept C2776804153 @default.
• W2403409882 hasConcept C2777014857 @default.
• W2403409882 hasConcept C2777037409 @default.
• W2403409882 hasConcept C2777129736 @default.
• W2403409882 hasConcept C2777699602 @default.
• W2403409882 hasConcept C2779134260 @default.
• W2403409882 hasConcept C2779758542 @default.
• W2403409882 hasConcept C2780333948 @default.
• W2403409882 hasConcept C2781069245 @default.
• W2403409882 hasConcept C2781142857 @default.
• W2403409882 hasConcept C2781197716 @default.
• W2403409882 hasConcept C55493867 @default.
• W2403409882 hasConcept C71924100 @default.
• W2403409882 hasConcept C86803240 @default.
• W2403409882 hasConcept C95444343 @default.
• W2403409882 hasConceptScore W2403409882C126322002 @default.
• W2403409882 hasConceptScore W2403409882C142724271 @default.
• W2403409882 hasConceptScore W2403409882C177713679 @default.
• W2403409882 hasConceptScore W2403409882C185592680 @default.
• W2403409882 hasConceptScore W2403409882C189165786 @default.
• W2403409882 hasConceptScore W2403409882C203014093 @default.
• W2403409882 hasConceptScore W2403409882C2776042228 @default.
• W2403409882 hasConceptScore W2403409882C2776301714 @default.
• W2403409882 hasConceptScore W2403409882C2776804153 @default.
• W2403409882 hasConceptScore W2403409882C2777014857 @default.
• W2403409882 hasConceptScore W2403409882C2777037409 @default.
• W2403409882 hasConceptScore W2403409882C2777129736 @default.
• W2403409882 hasConceptScore W2403409882C2777699602 @default.
• W2403409882 hasConceptScore W2403409882C2779134260 @default.
• W2403409882 hasConceptScore W2403409882C2779758542 @default.
• W2403409882 hasConceptScore W2403409882C2780333948 @default.
• W2403409882 hasConceptScore W2403409882C2781069245 @default.
• W2403409882 hasConceptScore W2403409882C2781142857 @default.
• W2403409882 hasConceptScore W2403409882C2781197716 @default.
• W2403409882 hasConceptScore W2403409882C55493867 @default.
• W2403409882 hasConceptScore W2403409882C71924100 @default.
• W2403409882 hasConceptScore W2403409882C86803240 @default.

• next